Investors / United Kingdom / Oxford Investment Consultants
Oxford Investment Consultants
Venture capital · Oxford, United Kingdom · Europe
Oxford Investment Consultants is an FCA-authorised firm that operates OTIF Ventures, which invests in early-stage, EIS-eligible spinout companies from UK universities. It provides sophisticated investors with access to university deep-science spinouts through a tax-efficient EIS structure.
Invests inHealthcare & BiotechAI & Machine LearningIndustrial & Manufacturing
In its own wordsuniversity spinoutsdeep techlife sciencesphysical sciencesquantum computingeis
Your fit with Oxford Investment Consultants
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsOxford Investment Consultants lists 30 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (42%), AI & Machine Learning (20%) and Industrial & Manufacturing (17%). 86% of its companies are based in United Kingdom. It invests most often alongside Oxford Science Enterprises, Longwall Ventures and Perivoli Innovations Venture Investment Trust.
Counts come from funding rounds that name Oxford Investment Consultants, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Oxford Investment Consultants' whole history. Rounds on record name 2 companies; its own site lists 30. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 68th | 30 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 75th | 42% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Oxford Science Enterprises | 11 |
| Longwall Ventures | 8 |
| Perivoli Innovations Venture Investment Trust | 8 |
| Future Planet Capital | 7 |
| BGF | 3 |
| British Business Bank | 3 |
| Bullhound Capital | 2 |
| Creative Destruction Lab | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2997%
- No longer answers00%
- Points to another company13%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 42% | 15% |
| AI & Machine Learning | 20% | 18% |
| Industrial & Manufacturing | 17% | 7% |
| Enterprise Software | 7% | 8% |
| Cybersecurity | 7% | 4% |
| Education | 5% | 7% |
| Food & Agriculture | 2% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Oxford Science Enterprises
Compare Oxford Investment Consultants head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Oxford Investment Consultants| Date | Company | Stage |
|---|---|---|
| 5 Oct 2026 | Series A | |
| 2 Jun 2026 | Series C+ |
Round details for Oxford Investment Consultants
Amounts, full round histories and every co-investor in Oxford Investment Consultants' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
30 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| BibliU partners with colleges and universities to deliver a fully integrated campus store experience—combining affordable, Day 1 access to course materials with hybrid physical and online retail. | Education | Portfolio page | ||
| Biofidelity makes genomic biomarker detection simple, fast and reliable, enabling more patients to get the right treatment at the right time. | Healthcare & Biotech | Portfolio page | ||
| Brill Power makes batteries perform better, live longer, cost less and be more sustainable through its Battery Intelligence Platform | EducationIndustrial & Manufacturing | Portfolio page | ||
| Caristo Diagnostics develops and provides technology for cardiac disease diagnosis and prevention, including the CaRi-Heart technology to measure coronary inflammation and assess cardiovascular mortality risk. | Healthcare & Biotech | Portfolio page | ||
| Diffblue creates comprehensive and high-quality test coverage with developer intervention using AI coding tools | AI & Machine LearningEnterprise Software | Portfolio page | ||
| IotaSciences offers efficient automation solutions for gentle single-cell isolation and single-cell cloning, as well as expert cell-line engineering services | Healthcare & Biotech | Portfolio page | ||
| Keit develops and provides real-time process monitoring technology, including the IRmadillo analyzer, for various industries | Industrial & ManufacturingFood & Agriculture | Portfolio page | ||
| The company develops a platform for single-cell functional analysis to accelerate discovery and apply novel biological insights in research and drug discovery. | Healthcare & Biotech | Portfolio page | ||
| LIO brings together ambient monitoring, digital observations and management insights in one unified platform for inpatient facilities. | Healthcare & Biotech | Portfolio page | ||
| Living Optics develops hyperspectral imagers that are affordable and easy to use. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| Living Optics develops hyperspectral imagers that are affordable and easy to use | Healthcare & BiotechAI & Machine Learning | Oct 2026Series A | Funding round | |
| NiTech Solutions accelerates energetic production through continuous flow processing | Industrial & Manufacturing | Portfolio page | ||
| OQC builds quantum computers specifically engineered for commercial advantage and provides Quantum-Compute-as-a-Service | Enterprise SoftwareCybersecurity | Jun 2026Series C+ | Funding round | |
| OrganOx develops technologies to enhance organ transplantation, including normothermic machine perfusion | Healthcare & Biotech | Portfolio page | ||
| Orthoson develops a bio-structural gel to treat back pain and degeneration of the intervertebral disc | Healthcare & Biotech | Portfolio page | ||
| OSSTEC develops and provides biomimetic cementless fixation technology for joint replacement surgery | Healthcare & Biotech | Portfolio page | ||
| Oxeco develops ultra thin coatings using breakthrough approaches to surface modification | Industrial & Manufacturing | Portfolio page | ||
| The company engineers and manufactures valves and regulators for various industrial applications. | Industrial & ManufacturingIndustrial & Manufacturing | Portfolio page | ||
| Oxford Space Systems offers a portfolio of antennas aimed at improving performance, maximising stowage efficiency and minimising mass for space based services. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Oxford Brain Diagnostics analyses the cellular structure of the brain to support drug development and aid clinicians in their fight to defeat Alzheimer's and other neurodegenerative conditions. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- otif.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 2 Jun 2026
- Companies checked
- 30
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Oxford Investment Consultants' profile as data
Pull Oxford Investment Consultants' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/otif.vc
# also
GET /v1/firms/otif.vc/portfolio
GET /v1/firms/otif.vc/coinvestors
GET /v1/firms/otif.vc/news